These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Replacement of the quadricuspid aortic valve: strategy to avoid complete heart block. Pirundini PA; Balaguer JM; Lilly KJ; Gorsuch WB; Taft MB; Cohn LH; Rizzo RJ Ann Thorac Surg; 2006 Jun; 81(6):2306-8. PubMed ID: 16731182 [TBL] [Abstract][Full Text] [Related]
50. The utility of trans-catheter aortic valve replacement after commercialization: does the European experience provide a glimpse into the future use of this technology in the United States? Linke A; Walther T; Schuler G Catheter Cardiovasc Interv; 2010 Mar; 75(4):511-8. PubMed ID: 20088019 [TBL] [Abstract][Full Text] [Related]
51. Early structural valve deterioration of 18-mm Sorin Soprano aortic pericardial bioprosthesis. López Almodóvar LF; Lima P; Cañas A; Buendía J; Monguió E J Thorac Cardiovasc Surg; 2010 Apr; 139(4):e66-7. PubMed ID: 19660288 [No Abstract] [Full Text] [Related]
52. [Percutaneous implantation of aortic valve prosthesis in patients with symptomatic severe aortic stenosis rejected for surgical valve replacement]. Moreno R; Calvo L; Filgueiras D; López T; Sánchez-Recalde A; Jiménez-Valero S; Galeote G; López-Sendón JL Rev Esp Cardiol; 2008 Nov; 61(11):1215-9. PubMed ID: 19000498 [TBL] [Abstract][Full Text] [Related]
55. ECG of the month. Dyspnea and palpitations 16 years after tricuspid and aortic valve replacement. Atrial tachycardia (possibly slow atrial flutter) with 4:3 type I (Wenckebach) atrioventricular block, right bundle branch block, and left anterior fascicular block. Glancy DL; Jaligam VR; Saye VB; Wilklow FE J La State Med Soc; 2006; 158(1):5-6. PubMed ID: 16602476 [No Abstract] [Full Text] [Related]
56. Adherence to patient selection criteria in patients undergoing transcatheter aortic valve implantation with the 18F CoreValve ReValving System. Piazza N; Otten A; Schultz C; Onuma Y; Garcia-Garcia HM; Boersma E; de Jaegere P; Serruys PW Heart; 2010 Jan; 96(1):19-26. PubMed ID: 19744965 [TBL] [Abstract][Full Text] [Related]
57. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Gotzmann M; Lindstaedt M; Bojara W; Mügge A; Germing A Am Heart J; 2010 May; 159(5):926-32. PubMed ID: 20435207 [TBL] [Abstract][Full Text] [Related]
58. Percutaneous implantation of the self-expandable CoreValve for high risk patients with severe aortic valve stenosis: early Israeli experience. Danenberg H; Finkelstein A; Kornowski R; Segev A; Dvir D; Gilon D; Keren G; Sagie A; Feinberg M; Schwammenthal E; Banai S; Lotan C; Guetta V Isr Med Assoc J; 2010 Aug; 12(8):468-71. PubMed ID: 21337814 [TBL] [Abstract][Full Text] [Related]
59. The left axillary artery--a new approach for transcatheter aortic valve implantation. De Robertis F; Asgar A; Davies S; Delahunty N; Kelleher A; Trimlett R; Mullen M; Moat N Eur J Cardiothorac Surg; 2009 Nov; 36(5):807-12. PubMed ID: 19713120 [TBL] [Abstract][Full Text] [Related]
60. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Grube E; Laborde JC; Gerckens U; Felderhoff T; Sauren B; Buellesfeld L; Mueller R; Menichelli M; Schmidt T; Zickmann B; Iversen S; Stone GW Circulation; 2006 Oct; 114(15):1616-24. PubMed ID: 17015786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]